Economic Evaluation of Losses From Invalidism of the Population in Russia: Approaches and Methods

Topic. Economic evaluation of losses from invalidism of the population as an important component of a balanced decision-making in health and social policy (in particular, as concerns the programs of social well-being, adaptation and rehabilitation of invalided persons).
Purpose. Analysis of modern approaches and methods of economic evaluation of losses from invalidism of the population (from the point of view of completeness and correctness of the assessment, applicability, taking into account peculiarities of statistical surveying in the Russian Federation).
Methodology.On the basis of theoretical analysis of the legal and literature sources (the official Methodology of calculating economic losses from mortality, morbidity and invalidism of the population and the research articles presented in the RISC database from 2000 to 2016) we summarize the main approaches to economic evaluation of losses from invalidism of the population of the Russian Federation. There were also differentiated and formalized the main problems of economic evaluation of losses from disability.
Results.There were analyzed different approaches and methods of economic evaluation of losses from invalidism of the population used in the Russian Federation. We identified and highlighted the advantages and disadvantages of considered methods. There were formulated conceptual and methodological problems of economic evaluation of losses from invalidism of the population (such as completeness and quality of baseline data, problems of evaluation of current and deferred direct and indirect losses (loss of production of the manufactured product), etc.).
Conclusions. The main problems in the assessment of economic losses from invalidism in the Russian Federation at the present stage are the lack of disaggregated data on invalidated persons and lack of uniform and complete assessment techniques applicable for the purposes of comparison of costs and benefits by the state authorities. It is noted that the question of the adequacy and completeness of the data can be solved by using the Federal state information system “Federal register of disabled persons”, which is being introduced from 2017.

1. Shmakov D.I. Development of procedure for estimating the losses of health capital. Nauchnye trudy: Institut narodnokhozyaistvennogo prognozirovaniya RAN = Scientific works: Institute of economic forecasting of Russian Academy of Sciences, 2004, no. 2, pp. 527–539. (In Russ.).

2. Revich B.A., Sidorenko, V. N. Procedure of assessment of economic damage to public health from air pollution. A manual on regional environmental policy. Moscow: Akropol, CEPR, 2006. 42 p. (In Russ.)

3. Mikhailova Yu. V., Ivanova A.E. (eds). Socio-economic aspects of invalidism. Moscow: RIO CNIIOIZ, 2006. 136 p. (In Russ.)

4. Medik V.A., Yuryev V.K. Public health and health care: textbook. Moscow: Professional, 2009. 363 p. (In Russ.)

5. Nemstsveridze E.Ya. Methodical approaches to assessing economic losses due to invalidism of the working population in the Moscow region. Sotsial’nye aspekty zdorov’ya naseleniya = Social aspects of population health, 2012, no. 3 (25), p. 3. (In Russ.)

6. Sorokoletov D. V., Dubrovin G. M., Kirichenko Yu. N., Razinkov D. V. Injuries and diseases of the musculoskeletal system as one of the most important problems of permanent disability for work leading to significant economic losses of the society. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» = Kurskiy scientific-practical bulletin “Man and his health”, 2012, no. 4, pp. 102–107. (In Russ.)

7. Efros L.A. The economic damage from health losses of patients with coronary heart disease after coronary bypass surgery. Vestnik YuUrGU. Seriya «Obrazovanie, zdravookhranenie, fizicheskaya kul’tura» = Bulletin of YuUrSU. Series “Education, health care, physical culture”, 2013, vol. 13, no. 1, pp. 108–114. (In Russ.)

8. Guseva N.K., German S.V. Estimation of economic losses due to adult population invalidism in the Nizhni Novgorod region in 2002–2012. Sotsial’nye aspekty zdorov’ya naseleniya = Social aspects of population health, 2014, no. 2, pp. 4–5. (In Russ.)

9. Egorshin A. P., Polina N.A. The economic effect of reducing the level of morbidity and invalidism of population. Zdravookhranenie Rossiiskoi Federatsii = Healthcare of the Russian Federation, 2015, vol. 59, no. 1, pp. 22–5. (In Russ.)

10. Yagudina R. I., Serpik V. G. Methodology of cost analysis. Farmakoekonomika: teoriya i praktika = Pharmacoeconomics: theory and practice, 2016, no. 2, pp. 3–14. (In Russ.)

11. Yagudina R.I., Kulikov A. Yu., Metelkin A.I. Methodology of the analysis “cost-effectiveness” in conducting pharmacoeconomic studies. Sovremennaya farmakoekonomika i farmakoepidemiologiya = Pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiology, 2012, no. 4, pp. 3–8. (In Russ.)

12. Khabriev R.U., Kulikov A. Yu., Arinina E.E. Methodological foundations of pharmacoeconomic analysis. Moscow: JSC “Publishing house “Medicine”, 2011. 128 p. (In Russ.)

13. Omel’yanovskiy V. V., Avksent’eva M. V., Derkach E.V., Sveshnikova N.D. Methodical problems of analysis of cost of illness. Meditsinskie tekhnologii. Otsenka i vybor = Medical technologies. Evaluation and selection, 2011, no. 1, pp. 42–50. (In Russ.)

14. Goleva O.I. Assessment of tax losses from mortality and morbidity of the population: approaches to evaluation (on the example of Perm Krai). Permskii finansovyi zhurnal = Perm financial journal, 2016, no. 1 (14), pp. 51–59. (In Russ.)

15. Surkova I.V., Leshchuk S.I. Calculation of economic damage from the environmentally caused morbidity of the population. Methodological guidelines. Nauka i obrazovanie: novoe vremya = Science and education: new time, 2016, no. 2 (13), pp. 62–73. (In Russ.)

16. Yagudina R. I., Serpik V. G. On the possibilities of combining “budget impact” analysis and “costeffectiveness” analysis — the creation of “3D” pharmacoeconomic model. Farmakoekonomika: teoriya i praktika = Pharmacoeconomics: theory and practice, 2014, vol. 2, no. 3, pp. 4–8. (In Russ.)

17. Ryazhenov V.V., Gorokhova S.G., Bunyatyan N. D. Analysis of the impact on the budget: features of application of the method. Farmatsiya = Pharmacy, 2011, no. 1, pp. 41–44. (In Russ.)

18. Krot K.V., Slobodenyuk E.V., Meshalkin S. Yu. Analysis of “budget impact” of modern drugs for the treatment of schizophrenia: regional aspects. Kachestvennaya klinicheskaya praktika = Qualitative clinical practice, 2016, no. 1, pp. 34–40. (In Russ.)

19. Sullivan Sean D., Mauskopf Josephine A., Augustovski Federico, et al. Principles of Good Practice for Budget Impact Analysis II: Report of the ISPOR Task Force on Good Research Practices — Budget Impact Analysis. Value in Health, 2014, no. 17, pp. 5–14. URL: https://www.ispor.org/GoodOutcomesResearchPractices/Budget-Impact-Analyses_Russian.pdf.